Matthew Frankel, MD
ChemomAb Ltd.
3
0
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
General Manager
Tanabe Pharma Corporation
Shared therapeutic areas:
Kavita Juneja, MD
Corcept Therapeutics
Shared therapeutic areas:
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Elizabeth J Parks, PhD
University of Missouri-Columbia
Shared therapeutic areas:
Deran Oskay, Prof
Gazi University
Shared therapeutic areas:
Kartik Jhaveri, MD
University Health Network, Toronto
Shared therapeutic areas:
Chadwick Prodromos, MD
The Foundation for Orthopaedics and Regenerative Medicine
Shared therapeutic areas:
Nezam Afdhal, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
Theo Heller, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
CM-101 in NASH Patients - The SPLASH Study
CM-101 in PSC Patients -The SPRING Study
Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic Sclerosis
All 3 trials loaded